» Articles » PMID: 18322163

Epigenetic Regulation of BMP7 in the Regenerative Response to Ischemia

Overview
Specialty Nephrology
Date 2008 Mar 7
PMID 18322163
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Kidneys damaged by ischemia have the potential to regenerate through a mechanism involving intrarenal induction of protective factors, including bone morphogenetic protein-7 (BMP7). Epigenetic changes, such as alterations in histone modifications, have also been shown to play a role in various pathologic conditions, but their involvement in ischemic injury and regeneration remains unknown. This study investigated whether changes in histone acetylation, regulated by histone acetyltransferase and histone deacetylase (HDAC), are induced by renal ischemia and involved in the regenerative response. Ischemia/reperfusion of the mouse kidney induced a transient decrease in histone acetylation in proximal tubular cells, likely as a result of a decrease in histone acetyltransferase activity as suggested by experiments with energy-depleted renal epithelial cells in culture. During recovery after transient energy depletion in epithelial cells, the HDAC isozyme HDAC5 was selectively downregulated in parallel with the return of acetylated histone. Knockdown of HDAC5 by RNAi significantly increased histone acetylation and BMP7 expression. BMP7 induction and HDAC5 downregulation in the recovery phase were also observed in proximal tubular cells in vivo after transient ischemia. These data indicate that ischemia induces dynamic epigenetic changes involving HDAC5 downregulation, which contributes to histone re-acetylation and BMP7 induction in the recovery phase. This highlights HDAC5 as a modulator of the regenerative response after ischemia and suggests HDAC5 inhibition may be a therapeutic strategy to enhance BMP7 expression.

Citing Articles

[Role of Histone Modifications in Acute Kidney Injury Progressing to Chronic Kidney Disease].

Guo S, Zhang Z, Zhao J, Yuan J, Sun S Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 54(6):1080-1084.

PMID: 38162077 PMC: 10752784. DOI: 10.12182/20231160506.


Functioning and mechanisms of PTMs in renal diseases.

Liu Z, Yang J, Du M, Xin W Front Pharmacol. 2023; 14:1238706.

PMID: 38074159 PMC: 10702752. DOI: 10.3389/fphar.2023.1238706.


Histone Modifications in Acute Kidney Injury.

Wang J, Shen F, Liu F, Zhuang S Kidney Dis (Basel). 2023; 8(6):466-477.

PMID: 36590679 PMC: 9798838. DOI: 10.1159/000527799.


Histone Deacetylases Cooperate with NF-κB to Support the Immediate Migratory Response after Zebrafish Pronephros Injury.

Zhuang M, Scholz A, Walz G, Yakulov T Int J Mol Sci. 2022; 23(17).

PMID: 36076983 PMC: 9455417. DOI: 10.3390/ijms23179582.


Class IIa histone deacetylase inhibition ameliorates acute kidney injury by suppressing renal tubular cell apoptosis and enhancing autophagy and proliferation.

Li J, Yu C, Shen F, Cui B, Liu N, Zhuang S Front Pharmacol. 2022; 13:946192.

PMID: 35935816 PMC: 9354984. DOI: 10.3389/fphar.2022.946192.


References
1.
Kuznetsov G, Bush K, Zhang P, Nigam S . Perturbations in maturation of secretory proteins and their association with endoplasmic reticulum chaperones in a cell culture model for epithelial ischemia. Proc Natl Acad Sci U S A. 1996; 93(16):8584-9. PMC: 38716. DOI: 10.1073/pnas.93.16.8584. View

2.
Bolden J, Peart M, Johnstone R . Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006; 5(9):769-84. DOI: 10.1038/nrd2133. View

3.
Sasaki T, Iwata S, Okano H, Urasaki Y, Hamada J, Tanaka H . Nedd9 protein, a Cas-L homologue, is upregulated after transient global ischemia in rats: possible involvement of Nedd9 in the differentiation of neurons after ischemia. Stroke. 2005; 36(11):2457-62. DOI: 10.1161/01.STR.0000185672.10390.30. View

4.
Wetzel P, Haag J, Campean V, Goldschmeding R, Atalla A, Amann K . Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron. Kidney Int. 2006; 70(4):717-23. DOI: 10.1038/sj.ki.5001653. View

5.
Kelly K, Plotkin Z, Dagher P . Guanosine supplementation reduces apoptosis and protects renal function in the setting of ischemic injury. J Clin Invest. 2001; 108(9):1291-8. PMC: 209442. DOI: 10.1172/JCI13018. View